Log in

RPG Life Sciences

NSE: RPGLIFE · ISIN INE105J01010 · Healthcare

₹2,627.70+48.70 (+1.89%)

Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.

Price chart

₹2,627.70 +48.70 (+1.89%) today

The day

Previous close
₹2,579.00
Open
₹2,573.00
Day high
₹2,649.30
Day low
₹2,573.00

Listed on NSE since 10 June 2008.

Key numbers

Market value
₹4,342.15 Cr
P/E (trailing)
39.57
EPS (trailing)
₹66.35
Price to book
5.95
Dividend yield
0.93%
Return on equity
15.6%
Debt to equity
0.03
Profit margin
14.3%
Beta
-0.05
Volume today
6,539
Average volume
27,471

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹509.08 Cr₹67.64 Cr₹40.90
FY24₹577.48 Cr₹87.66 Cr₹53.01
FY25₹647.54 Cr₹183.24 Cr₹110.80
FY26₹702.00 Cr₹115.17 Cr₹69.64

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹212 Cr₹27 Cr₹17.07–
Q1 FY27Apr–Jun 2026₹196 Cr₹0₹18.60–
Q4 FY26Jan–Mar 2026Audited₹177 Cr₹30 Cr₹18.08–
Q3 FY26Oct–Dec 2025₹180 Cr₹0₹13.38–

Source: RPG Life Sciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of RPG Life Sciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026
Fixed assets₹371 Cr₹212 Cr
Investments₹165 Cr₹84 Cr
Inventories₹173 Cr₹124 Cr
Owed by customers₹141 Cr₹117 Cr
Cash and equivalents₹111 Cr₹150 Cr
Total assets₹1,116 Cr₹793 Cr
Borrowings₹22 Cr₹20 Cr
Total liabilities₹250 Cr₹188 Cr
Shareholders’ equity₹687 Cr₹605 Cr

Source: RPG Life Sciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About RPG Life Sciences

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Industry
Drug Manufacturers - Specialty & Generic
Based in
Mumbai
Employees
1,366

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name RPG Life Sciences in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Rs 24 Per Share

    Dividend · ex-date 9 July 2026

  • Dividend - Rs 20 Per Share/ Special Dividend - Rs 4 Per Share

    Dividend · ex-date 27 June 2025

  • Dividend - Rs 16 Per Share

    Dividend · ex-date 28 June 2024

  • Dividend - Rs 12 Per Share

    Dividend · ex-date 21 July 2023

  • Dividend - Rs 9.60 Per Share

    Dividend · ex-date 14 July 2022 · record date 15 July 2022

  • Dividend - Rs 7.20 Per Share

    Dividend · ex-date 13 August 2021 · record date 17 August 2021

  • Interim Dividend - Rs 4 Per Share

    Dividend · ex-date 24 March 2020 · record date 26 March 2020

  • Annual General Meeting/ Dividend - Rs 2.40 Per Share

    Dividend · ex-date 22 July 2019

Source: NSE. Latest first, 8 of 20.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.